Relevant Data

Food Additives Approved by WHO:


General Information

MaintermDEHYDRONOOTKATONE
Doc TypeEAF
CAS Reg.No.(or other ID)5090-63-1
Regnum

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID71586808
IUPAC Name(4R,4aS,6S)-4,4a-dimethyl-6-prop-1-en-2-yl-3,4,5,6-tetrahydronaphthalen-2-one
InChIInChI=1S/C15H20O/c1-10(2)12-5-6-13-8-14(16)7-11(3)15(13,4)9-12/h5-6,8,11-12H,1,7,9H2,2-4H3/t11-,12-,15+/m1/s1
InChI KeyPHRADXUJOZKVDN-JMSVASOKSA-N
Canonical SMILESCC1CC(=O)C=C2C1(CC(C=C2)C(=C)C)C
Molecular FormulaC15H20O
Wikipediadehydronootkatone

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight216.324
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count1
Complexity400.0
CACTVS Substructure Key Fingerprint A A A D c e B w I A A A A A A A A A A A A A A A A A A A A A A A A A A g Q A A A A A A A A A C A A A A A G g A A A A A A D w S A g A A C A A A A A A C I A q B S A A A A A A A g A A A I C A E A A E g I A B I A A Q A A A A A A g A A I g Q M I i M C P g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area17.1
Monoisotopic Mass216.151
Exact Mass216.151
XLogP3None
XLogP3-AA3.8
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count16
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9526
Human Intestinal AbsorptionHIA+1.0000
Caco-2 PermeabilityCaco2+0.7870
P-glycoprotein SubstrateSubstrate0.6075
P-glycoprotein InhibitorInhibitor0.8447
Non-inhibitor0.8446
Renal Organic Cation TransporterNon-inhibitor0.7866
Distribution
Subcellular localizationMitochondria0.4836
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8476
CYP450 2D6 SubstrateNon-substrate0.8483
CYP450 3A4 SubstrateSubstrate0.6607
CYP450 1A2 InhibitorNon-inhibitor0.7276
CYP450 2C9 InhibitorNon-inhibitor0.8223
CYP450 2D6 InhibitorNon-inhibitor0.9044
CYP450 2C19 InhibitorInhibitor0.5309
CYP450 3A4 InhibitorInhibitor0.5648
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.6881
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.8941
Non-inhibitor0.8598
AMES ToxicityNon AMES toxic0.8641
CarcinogensNon-carcinogens0.8488
Fish ToxicityHigh FHMT0.9930
Tetrahymena Pyriformis ToxicityHigh TPT0.8560
Honey Bee ToxicityHigh HBT0.8837
BiodegradationNot ready biodegradable0.9931
Acute Oral ToxicityIII0.6987
Carcinogenicity (Three-class)Non-required0.4766

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-3.7892LogS
Caco-2 Permeability2.0697LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.4258LD50, mol/kg
Fish Toxicity0.0223pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.7526pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassPrenol lipids
SubclassSesquiterpenoids
Intermediate Tree NodesNot available
Direct ParentEremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids
Alternative Parents
Molecular FrameworkAliphatic homopolycyclic compounds
SubstituentsEremophilane sesquiterpenoid - Cyclohexenone - Cyclic ketone - Ketone - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic homopolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as eremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids. These are sesquiterpenoids with a structure based either on the eremophilane skeleton, its 8,9-seco derivative, or the furoeremophilane skeleton. Eremophilanes have been shown to be derived from eudesmanes by migration of the methyl group at C-10 to C-5.

From ClassyFire